Neural Organoid Models as a Platform for Studying Disease Mechanisms in Amyotrophic Lateral Sclerosis
Journal of Neurochemistry · 2026-07 · 170 (7)
DOI: 10.1111/jnc.70513 ↗At a glance
Übersichtsarbeit in Journal of Neurochemistry, published online on 2026-07-01. Written by Kristel N Eigenhuis and 2 co-authors. Institution: Department of Translational Neuroscience, University Medical Center Utrecht, Utrecht, CG, the Netherlands. Major MEDLINE topics: Amyotrophic Lateral Sclerosis, Organoids, Induced Pluripotent Stem Cells, Neurons. Cited 3 times so far (Crossref); 79 references. The full text is freely available (open access, CC BY 4.0). Funded by: Stichting ALS Nederland.
Abstract (original language)
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder affecting upper and lower motor neurons leading to muscle wasting. However, structural and molecular abnormalities, including cortical thinning and TDP‐43 pathology, extend into frontal, parietal, and temporal areas, pointing to defects across broader cortical regions. The advent of human induced pluripotent stem cell (hiPSC) technology has enabled the generation of human‐specific brain cell types in vitro. Here, we provide an overview of the three‐dimensional (3D) hiPSC‐derived neural organoid platforms used to model cortical structures and to study cortical ALS‐associated phenotypes. We review which pathological hallmarks have been recapitulated in these organoids and discuss disease phenotypes reported to date. Further, we comprehensively cover different neural organoid models and experimental strategies, including patient‐derived hiPSC models and exogenous pathology induction, while addressing current technical challenges. Together, these advances position neural organoids as an emerging tool to study cell‐type‐specific and circuit‐level mechanisms related to cortical changes in ALS. image
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- Department of Translational Neuroscience, University Medical Center Utrecht, Utrecht, CG, the Netherlands.
Funding
- Stichting ALS Nederland
Cite
APA
Eigenhuis, K. N., Ferrer, R. M., & Pasterkamp, R. J. (2026). Neural Organoid Models as a Platform for Studying Disease Mechanisms in Amyotrophic Lateral Sclerosis. Journal of Neurochemistry, 170(7). https://doi.org/10.1111/jnc.70513
Vancouver
Eigenhuis KN, Ferrer RM, Pasterkamp RJ. Neural Organoid Models as a Platform for Studying Disease Mechanisms in Amyotrophic Lateral Sclerosis. Journal of Neurochemistry. 2026;170(7). doi:10.1111/jnc.70513
BibTeX
@article{Eigenhuis2026,
author = {Eigenhuis, Kristel N and Ferrer, Roberto Montoro and Pasterkamp, R Jeroen},
title = {Neural Organoid Models as a Platform for Studying Disease Mechanisms in Amyotrophic Lateral Sclerosis},
journal = {Journal of Neurochemistry},
year = {2026},
volume = {170},
number = {7},
doi = {10.1111/jnc.70513}
}
EUVIMED